Future of breast screening at risk over payouts
BreastCheck’s national clinical director, Ann O’Doherty, said her biggest fear was that the litigation was going to be so costly that politicians would stop funding screening and put the resources into symptomatic breast cancer services.
Prof O’Doherty said she has worked in breast screening for 30 years and would not have more than one medico-legal case a year.
Lunchtime News
Newsletter
Get a lunch briefing straight to your inbox at noon daily. Also be the first to know with our occasional Breaking News emails.



